DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,893,370 | +102379.5% | 39,877 | -0.9% | 1.60% | +3.7% |
| Q2 2023 | $9,654 | -5.8% | 40,226 | -1.0% | 1.55% | -11.3% |
| Q1 2023 | $10,243 | -4.2% | 40,640 | +0.8% | 1.74% | -10.8% |
| Q4 2022 | $10,696 | -99.9% | 40,299 | -0.7% | 1.95% | -5.1% |
| Q3 2022 | $10,477,000 | +1.7% | 40,565 | -0.1% | 2.06% | +5.5% |
| Q2 2022 | $10,297,000 | -14.8% | 40,615 | -1.4% | 1.95% | +1.4% |
| Q1 2022 | $12,081,000 | -12.5% | 41,186 | -1.8% | 1.92% | -3.8% |
| Q4 2021 | $13,803,000 | +7.1% | 41,952 | -0.9% | 2.00% | -1.0% |
| Q3 2021 | $12,886,000 | +13.4% | 42,327 | -0.1% | 2.02% | +12.9% |
| Q2 2021 | $11,366,000 | +17.8% | 42,354 | -1.2% | 1.79% | +10.0% |
| Q1 2021 | $9,645,000 | +1.9% | 42,854 | +0.6% | 1.62% | -3.6% |
| Q4 2020 | $9,462,000 | +2.5% | 42,593 | -0.6% | 1.68% | -9.1% |
| Q3 2020 | $9,228,000 | +20.1% | 42,853 | -1.4% | 1.85% | +9.1% |
| Q2 2020 | $7,682,000 | +27.1% | 43,443 | -0.5% | 1.70% | +4.0% |
| Q1 2020 | $6,045,000 | -11.0% | 43,677 | -1.3% | 1.63% | +13.1% |
| Q4 2019 | $6,794,000 | +5.8% | 44,266 | -0.4% | 1.44% | -2.4% |
| Q3 2019 | $6,419,000 | -0.4% | 44,441 | -1.5% | 1.48% | -0.9% |
| Q2 2019 | $6,446,000 | +7.6% | 45,105 | -0.6% | 1.49% | +2.1% |
| Q1 2019 | $5,988,000 | +26.3% | 45,355 | -1.4% | 1.46% | +9.9% |
| Q4 2018 | $4,742,000 | -6.2% | 45,989 | -1.1% | 1.33% | +12.0% |
| Q3 2018 | $5,053,000 | +10.0% | 46,498 | -0.1% | 1.19% | +1.7% |
| Q2 2018 | $4,593,000 | +0.4% | 46,543 | -0.3% | 1.17% | -0.6% |
| Q1 2018 | $4,573,000 | +4.6% | 46,702 | -0.8% | 1.17% | +6.0% |
| Q4 2017 | $4,371,000 | +8.5% | 47,096 | +0.3% | 1.11% | +3.1% |
| Q3 2017 | $4,029,000 | +0.5% | 46,966 | -1.1% | 1.08% | -0.6% |
| Q2 2017 | $4,009,000 | -0.3% | 47,500 | +1.1% | 1.08% | -2.3% |
| Q1 2017 | $4,020,000 | +13.1% | 46,999 | +3.0% | 1.11% | +6.3% |
| Q4 2016 | $3,553,000 | +20.0% | 45,644 | +20.8% | 1.04% | +14.0% |
| Q3 2016 | $2,962,000 | +56.1% | 37,789 | +101.0% | 0.91% | +58.0% |
| Q2 2016 | $1,898,000 | +55.4% | 18,796 | +46.0% | 0.58% | +49.0% |
| Q1 2016 | $1,221,000 | – | 12,873 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |